NUVB
Nuvation Bio Inc - Ordinary Shares - Class A

3,033
Mkt Cap
$1.47B
Volume
7.28M
52W High
$9.75
52W Low
$1.54
PE Ratio
-7.04
NUVB Fundamentals
Price
$4.22
Prev Close
$4.26
Open
$4.26
50D MA
$5.51
Beta
1.55
Avg. Volume
4.67M
EPS (Annual)
-$0.5991
P/B
4.66
Rev/Employee
$211,080.54
$2,743.76
Loading...
Loading...
News
all
press releases
NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nuvation Bio Inc. (NUVB or the Company) (NYSE: NUVB) for...
Business Wire·1d ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio...
PR Newswire·3d ago
News Placeholder
Nuvation Bio to Present Pivotal IBTROZI (Taletrectinib) Data in TKI-Nave and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
Nuvation Bio to Present Pivotal IBTROZI (Taletrectinib) Data in TKI-Nave and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 Nuvation Bio to Present...
PR Newswire·5d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio...
PR Newswire·10d ago
News Placeholder
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm PR Newswire NEW YORK, March 6, 2026 NEW YORK, March 6...
PR Newswire·16d ago
News Placeholder
Citigroup Inc. Has $3.42 Million Stake in Nuvation Bio Inc. $NUVB
Citigroup Inc. lowered its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 30.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·17d ago
News Placeholder
Nuvation Bio Inc. $NUVB is Aisling Capital Management LP's 4th Largest Position
Aisling Capital Management LP lifted its position in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 16.5% during the 3rd quarter, according to its most recent filing with the Securities and...
MarketBeat·19d ago
News Placeholder
UBS Group Lowers Nuvation Bio (NYSE:NUVB) Price Target to $7.00
UBS Group decreased their price objective on shares of Nuvation Bio from $10.00 to $7.00 and set a "neutral" rating on the stock in a report on Tuesday...
MarketBeat·19d ago
News Placeholder
NUVB Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Nuvation Bio Inc (Symbol: NUVB) crossed below their 200 day moving average of $4.43, changing hands as low as $4.26 per share. Nuvation Bio Inc shares are currently...
Nasdaq News: Markets·19d ago
News Placeholder
Nuvation Bio (NYSE:NUVB) Shares Gap Down - Should You Sell?
Nuvation Bio (NYSE:NUVB) Shares Gap Down - What's Next...
MarketBeat·19d ago
<
1
2
...
>

Latest NUVB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.